Mereo BioPharma Group plc (MREO) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.33 +6.45%
EPS Growth %: +50.0%
Financial Fact:
Product: 20.37K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +50.0%
Financial Fact:
Product: 20.37K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Mereo BioPharma Group plc (NASDAQ: MREO) reported Q1 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01.
For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Avis Budget Group reaches $650M settlement with Pentwater Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
